Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures
- PMID: 222690
- DOI: 10.1002/ijc.2910230505
Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures
Abstract
Regression of EB-virus-induced transformation occurs exclusively in cultures of leukocytes from seropositive donors. Studies have shown that the strength of regression could be assayed in terms of the proportion of T cells which must be added to the autologous EB virus-infected T-cell-depleted population in order to establish regression in the culture. The in vitro regression phenomenon was strongly T-cell-dependent but did not require the presence of either monocytes or, as a potential antigenic stimulus, the residual viral envelope material on the surface of virus-infected B cells. The T-cell-depleted population from seropositive donors sometimes transformed (7/60 cultures) without the experimental addition of virus. Regression appeared to be independent of cytotoxic mechanisms involving anti-viral antibodies and not to be mediated by soluble factors released into culture medium.
Similar articles
-
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.Int J Cancer. 1979 May 15;23(5):618-25. doi: 10.1002/ijc.2910230506. Int J Cancer. 1979. PMID: 222691
-
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.Int J Cancer. 1978 Dec;22(6):662-8. doi: 10.1002/ijc.2910220604. Int J Cancer. 1978. PMID: 214405
-
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.Int J Cancer. 1981 May 15;27(5):593-601. doi: 10.1002/ijc.2910270505. Int J Cancer. 1981. PMID: 6169663
-
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants.Cell Immunol. 1990 Apr 15;127(1):47-55. doi: 10.1016/0008-8749(90)90113-6. Cell Immunol. 1990. PMID: 1690609
-
Immunologic considerations in the selection of nonhuman primate models for studies of Epstein--Barr virus-associated diseases in man.Comp Immunol Microbiol Infect Dis. 1979;2(2-3):243-56. doi: 10.1016/0147-9571(79)90012-2. Comp Immunol Microbiol Infect Dis. 1979. PMID: 228898 Review. No abstract available.
Cited by
-
The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.Immunology. 1989 Apr;66(4):485-90. Immunology. 1989. PMID: 2541070 Free PMC article.
-
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.Proc Natl Acad Sci U S A. 1980 Jul;77(7):4247-50. doi: 10.1073/pnas.77.7.4247. Proc Natl Acad Sci U S A. 1980. PMID: 6254017 Free PMC article.
-
Epstein-Barr (EB) virus antibodies in rheumatoid arthritis.Springer Semin Immunopathol. 1981;4(2):181-91. doi: 10.1007/BF01857094. Springer Semin Immunopathol. 1981. PMID: 6275562 No abstract available.
-
Characterisation of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals.Br J Cancer. 1983 May;47(5):681-6. doi: 10.1038/bjc.1983.106. Br J Cancer. 1983. PMID: 6303377 Free PMC article.
-
Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.J Clin Invest. 2011 Mar;121(3):1130-40. doi: 10.1172/JCI43755. Epub 2011 Feb 21. J Clin Invest. 2011. PMID: 21339648 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources